BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15669429)

  • 1. [Perinatal group B streptococcal disease: a review and revised guidelines for prevention].
    Shrim A; Beiner M; Weisz B; Seidman DS
    Harefuah; 2004 Jul; 143(7):520-4, 548. PubMed ID: 15669429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: a prospective study.
    Lijoi D; Di Capua E; Ferrero S; Mistrangelo E; Giannattasio A; Morano S; Ragni N
    Arch Gynecol Obstet; 2007 May; 275(5):373-9. PubMed ID: 17047973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal group B streptococcal disease after universal screening recommendations--United States, 2003-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Jul; 56(28):701-5. PubMed ID: 17637595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Group B streptococcus colonization during pregnancy and prevention of early onset of disease].
    Larcher JS; Capellino F; De Giusto R; Travella C; Balangione FG; Kreiker G; Cardona HP; Zarate A; Vilaro M; Hernandez D; Ruiz Orrico G
    Medicina (B Aires); 2005; 65(3):201-6. PubMed ID: 16042129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoption of perinatal group B streptococcal disease prevention recommendations by prenatal-care providers--Connecticut and Minnesota, 1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Mar; 49(11):228-32. PubMed ID: 10763673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
    Verani JR; McGee L; Schrag SJ;
    MMWR Recomm Rep; 2010 Nov; 59(RR-10):1-36. PubMed ID: 21088663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital-based policies for prevention perinatal Group B streptococcal disease--United States, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Oct; 49(41):936-40. PubMed ID: 11063277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoption of hospital policies for prevention of perinatal group B streptococcal disease--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Aug; 47(32):665-70. PubMed ID: 9729032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevention of early-onset neonatal group B streptococcus infection: technical report from the New Zealand GBS Consensus Working Party.
    Campbell N; Eddy A; Darlow B; Stone P; Grimwood K;
    N Z Med J; 2004 Aug; 117(1200):U1023. PubMed ID: 15475993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.
    Pinto NM; Soskolne EI; Pearlman MD; Faix RG
    J Perinatol; 2003 Jun; 23(4):265-71. PubMed ID: 12774131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group B streptococcus: prevention of early-onset neonatal sepsis.
    Platt JS; O'Brien WF
    Obstet Gynecol Surv; 2003 Mar; 58(3):191-6. PubMed ID: 12612459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-onset and late-onset neonatal group B streptococcal disease--United States, 1996-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Dec; 54(47):1205-8. PubMed ID: 16319814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Policy statement—Recommendations for the prevention of perinatal group B streptococcal (GBS) disease.
    ; ; Baker CJ; Byington CL; Polin RA
    Pediatrics; 2011 Sep; 128(3):611-6. PubMed ID: 21807694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminishing racial disparities in early-onset neonatal group B streptococcal disease--United States, 2000-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jun; 53(23):502-5. PubMed ID: 15201842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of early-onset neonatal group B streptococcal infection: implications for screening.
    Konrad G; Katz A
    Can Fam Physician; 2007 Jun; 53(6):1055, 2001:e.1-6, 1054. PubMed ID: 17872785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inappropriate use of vancomycin for preventing perinatal group B streptococcal (GBS) disease in laboring patients.
    Peláez LM; Gelber SE; Fox NS; Chasen ST
    J Perinat Med; 2009; 37(5):487-9. PubMed ID: 19492913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of prophylaxis for group B streptococcal infections of the neonate.
    Baltimore RS
    Semin Perinatol; 2007 Feb; 31(1):33-8. PubMed ID: 17317425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization.
    Davis RL; Hasselquist MB; Cardenas V; Zerr DM; Kramer J; Zavitkovsky A; Schuchat A
    Am J Obstet Gynecol; 2001 Mar; 184(4):603-10. PubMed ID: 11262460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of early-onset invasive neonatal group B streptococcal disease in a private hospital setting: the superiority of culture-based protocols.
    Main EK; Slagle T
    Am J Obstet Gynecol; 2000 Jun; 182(6):1344-54. PubMed ID: 10871448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprophylaxis for group B streptococcus transmission in neonates.
    Beri R; Lourwood DL
    Ann Pharmacother; 1997 Jan; 31(1):110-2. PubMed ID: 8997476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.